Efficacy of Functional Magnetic Stimulation in Urinary Incontinence

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02091947

Acronym

FMS

Enrollment

Registered

2014-03-19

Start date

2010-11-30

Completion date

2014-06-30

Last updated

2014-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incontinence

Keywords

FMS, Urine incontinence

Brief summary

Functional Magnetic Stimulation (FMS) appears to modulate autonomic and somatic nervous systems that innervate the lower urinary tract. Stimulation of the pudendal afferent nerve near the third sacral root induces relaxation of the detrusor muscles and reinforcement of urethral sphincter. Some preliminary studies had indicated the positive effect of FMS on stress urinary incontinence. Investigators aimed to evaluate the immediate and long-term effect of this method on stress urinary incontinent patients.

Detailed description

5 Hz repetitive magnetic stimulation was applied over bilateral sacral roots for 20 minutes.

Interventions

DEVICEFMS (Magstim rapid2)

5 Hz FMS, over bilateral sacral roots.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Urine incontinence refractory to traditional treatment

Exclusion criteria

* Arrhythmia, pacemaker implantation

Design outcomes

Primary

Measure	Time frame
Symptom scoring on Urge-Urinary Distress Inventory questionnaire	up to 5 months

Secondary

Measure	Time frame
Cystometry and stress urethral pressure profile as measures of objective incontinence improvement	up to 5 months

Countries

Taiwan

Contacts

Primary ContactPo-Yi Tsai, MD

pytsai@vghtpe.gov.tw886-28757293

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026